(Q45867526)

English

Treatment characteristics and the risk of inhibitor development: a multicenter cohort study among previously untreated patients with severe hemophilia A.

scientific article published on 20 April 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17456190%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Treatment characteristics and the risk of inhibitor development: a multicenter cohort study among previously untreated patients with severe hemophilia A (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17456190%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

0 references

0 references

0 references

Saskia le Cessie

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17456190%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Johanna G van der Bom

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17456190%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Gouw SC

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17456190%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

van den Berg HM

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17456190%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

20 April 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17456190%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17456190%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17456190%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17456190%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1383-1390

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17456190%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

The epidemiology of inhibitors in haemophilia A: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02595.X

21 January 2018

Genetic predisposition to develop factor VIII antibody in classic hemophilia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02595.X

21 January 2018

Inhibitors occur more frequently in African-American and Latino haemophiliacs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02595.X

21 January 2018

The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor development in hemophilia patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02595.X

21 January 2018

Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02595.X

21 January 2018

Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02595.X

21 January 2018

Incidence of factor VIII inhibitors in severe haemophilia: the importance of patient age.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02595.X

21 January 2018

Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02595.X

21 January 2018

Environmental risk factors for inhibitor development in children with haemophilia A: a case-control study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02595.X

21 January 2018

Management of factor VIII inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02595.X

21 January 2018

Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02595.X

21 January 2018

Human recombinant DNA-derived antihemophilic factor in the treatment of previously untreated patients with hemophilia A: final report on a hallmark clinical investigation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02595.X

21 January 2018

Safety and efficacy of KOGENATE Bayer in previously untreated patients (PUPs) and minimally treated patients (MTPs).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02595.X

21 January 2018

The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02595.X

21 January 2018

The safety and efficacy of B-domain deleted recombinant factor VIII concentrates in patients with severe haemophilia A: an update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02595.X

21 January 2018

Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02595.X

21 January 2018

The danger model: a renewed sense of self

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2007.02595.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45867526&oldid=1086375696"